MIRA’S STORY
Our journey began with a mission to bring laboratory services closer to underserved communities during the 2020 pandemic. Today, we’re leading the way in precision medicine for pharmacies, clinics, and patients—empowering healthcare with personalized, innovative solutions.
Mira’s Beginning
Founded in 2020 during the global pandemic, Mira Precision Health—originally known as Mobility Health—began with a mission to bring molecular diagnostic testing closer to communities in need. Driven by the strength and empowerment embodied in the name Mira, our founder and CEO, Dr. Sandra Gunselman, envisioned more than just access to healthcare. Her goal was to reshape the future of precision medicine, ensuring that every clinic, pharmacy, and patient has the tools to make informed, data-driven decisions about their care.
As a certified member of the Women’s Business Enterprise National Council (WBENC), Dr. Gunselman exemplifies leadership and innovation in healthcare, advancing precision prescribing and pharmacogenomics (PGx) with a commitment to excellence. Mira’s story is one of empowerment, not only reflecting the strength of women but also the empowerment of healthcare providers to deliver precise, personalized care that transforms patient outcomes.
Mira’s Approach to Precision Medicine
Our team understands the frustration of trial-and-error treatments, which often result in side effects and delayed care. Finding the right medication can take years, leaving conditions poorly managed.
We’re committed to changing this by delivering innovative solutions that streamline workflows in pharmacies, clinics, and practices. Through precision medicine, we empower care teams to make better decisions, improving efficiency and patient outcomes.
Our Executive Leadership Team
Dr. Sandra Gunselman is a seasoned expert in molecular biology and laboratory operations, with over 25 years of experience building high-performance, cross-functional teams in the life sciences. She most recently served as Executive Director at National Jewish Health Advanced Diagnostics Laboratories, overseeing hospital, reference lab, and CRO businesses. Prior to that, she was Vice President of Laboratory Operations at Myriad Genetics, joining through the acquisition of Assurex Health.
Dr. Gunselman’s leadership extends across strategic direction, resource optimization, and technical project management. She excels in scaling operations, troubleshooting complex challenges, and driving successful outcomes in dynamic, multidisciplinary environments. Her previous roles include Vice President of Operations at Transgenomic, where she further honed her ability to lead large-scale initiatives.
Sandra holds a B.S. in Biology with a minor in Chemistry from David Lipscomb University and earned her Ph.D. in Cellular and Molecular Biology from Colorado State University.
Sandra Gunselman, PhD
Founder and CEO
Aaron Marcelli serves as the Chief Financial Officer of Mira Precision Health, bringing a wealth of financial expertise and over a decade of experience in managing and growing businesses. In addition to his role at Mira, Aaron has successfully owned and operated Marcelli Bookkeeping Services, providing tailored financial solutions to clients for nearly ten years.
Prior to joining Mira, Aaron was the CFO of Cross Plains Community Partners, where he led financial operations for approximately seven years, contributing to the company’s growth and long-term sustainability.
Aaron holds a Bachelor of Arts from Tennessee Temple University and earned his Master of Business Administration from Bryan College in Dayton, Tennessee.
Aaron Marcelli, MBA
Chief Financial Officer
Dr. Jazieh is Mira Precision Health’s Chief Medical Officer (CMO). He is also the CEO, Director of Research and Innovation, & Director of International Programs at Cincinnati Cancer Advisors, Cincinnati, OH, USA.
He is a former Chairman, Department of Oncology, and a Professor at King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, between 2006 and 2020. He is also the founding Director of the MENA Center for NCCN Collaboration, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia. He is a former Professor of Medicine and Chief of Hematology Oncology Division at the University of Cincinnati. Dr. Jazieh is a member of multiple professional societies, including the former Chairman of the International Affairs Committee of the American Society of Clinical Oncology (ASCO). Served on the SWOG Board of Governors between 2002 – 2005.Dr Jazieh established the Association of VA Hematology Oncology (avaho.org) in 2005.
He obtained his MD Degree from Damascus University, Syria, and his master’s in public health from Tulane University, New Orleans. He completed his Fellowship in Hematology and Medical Oncology at the University of Arkansas for Medical Sciences in Arkansas. He obtained the American Board of Internal Medicine, Hematology, and Medical Oncology.
Dr. Jazieh attained multiple honors and awards including Best Global Partner for NCCN in 2018, Merit Award Recipient from ASCO, “40 under 40” People to Watch at the UC Medical Center, “Unsung Hero Award” by Cancer Family Care, Cincinnati, and a Proclamation to the City of Cincinnati naming the day of January 5th, 2006 as Dr. Abdul Rahman Jazieh.
Besides his clinical interest in lung cancer and GI malignancies, Dr. Jazieh is working on improving healthcare innovations and quality of care, and serves as Editor in Chief for the Global Journal on Quality and Safety in Healthcare, and has 165+ publications
Abdul Rahman Jazieh, MD, MPH
Chief Medical Officer
Luke Drury, PhD, currently serves as the Vice President of Laboratory Operations and Clinical Lab Director. Luke is passionate about improving patient lives through diagnostic testing and brings over 12 years of experience in molecular diagnostics. Prior to joining Mira, he worked at PreventionGenetics, an Exact Sciences Company, in Marshfield, Wisconsin serving in several roles during his tenure including geneticist, sequencing department director, post-analytical department director, and clinical laboratory director. At PreventionGenetics he developed the hematology test portfolio, interpreted and drafted clinical reports, oversaw validations, and served on the leadership team.
He is certified as a High Complexity Laboratory Director in Molecular Diagnostics through the American Board of Bioanalysis, as a Diplomate of Laboratory Management through the American Society of Clinical Pathology, as a Molecular Biologist through the American Society of Clinical Pathology, and as a New York State Laboratory Director. He completed the Laboratory Management University and Leadership Institute Programs through the American Society of Clinical Pathology.
He has served on advisory boards, as a team lead for College of American Pathology inspections, as an expert panel member for the ClinGen ALS Gene Curation Working Group, and has been published 14 times. Dr. Drury received his PhD in Microbiology and Molecular Genetics from the Medical College of Wisconsin and was a postdoctoral research scholar at the University of Iowa.
Luke Drury, PhD
DLM(ASCP), HCLD(ABB), MB(ASCP)
Vice President, Laboratory Operations
Lori Borchers is the Vice President of Sales & Marketing at Mira Precision Health, bringing more than 20 years of commercial leadership in molecular diagnostics, pharmacogenomics, and precision medicine. She oversees Mira’s commercial strategy, sales organization, and national market expansion for Mira Precision PGx™ and the forthcoming U.S. launch of ToxNav® Advantage™.
Earlier in her career, Lori held key commercial positions across several healthcare and diagnostic companies, consistently driving revenue growth, strengthening provider relationships, and expanding clinical use of advanced testing solutions across cardiology, primary care, behavioral health, oncology, pain management, and wellness medicine.
At Mira Precision Health, Lori leads the development of scalable go-to-market strategies and the commercial infrastructure required to accelerate the adoption of Mira’s next-generation PGx and toxicity-risk assessment solutions. Her leadership is central to advancing Mira’s mission of delivering accessible and clinically meaningful precision medicine nationwide.
Lori holds a Bachelor of Arts in Communications from the University of Cincinnati.
Lori Borchers
Vice President, Sales & Marketing
Brett Miller is an accomplished commercial leader in precision medicine, oncology, and pharmacogenomics with more than 15 years of experience driving sales growth, building strategic partnerships, and advancing the clinical adoption of innovative diagnostic technologies. He joins Mira Precision Health as Vice President of Strategic Development, where he will support national expansion of Mira Precision PGx™ and ToxNav® Advantage™, working closely with providers, clinics, and health systems.
He holds a Bachelor of Arts in Communications and Psychology from Bethel University. At Mira Precision Health, Brett leverages deep expertise in PGx, oncology, and strategic development to help scale precision medicine nationwide.
Brett Miller
Vice President, Strategic Development
Scott Roth is the Vice President of Technology at Mira Precision Health, bringing over 25 years of leadership in Product and Engineering across startups and established companies. A lifelong problem solver, Scott’s passion for technology began in his youth with a Commodore Amiga, sparking a career dedicated to building innovative solutions that improve people’s lives.
Scott has a proven track record of developing and scaling high-performing teams across product management, software engineering, quality assurance, data management, IT, and security. He not only implements transformative processes and solutions but also fosters a culture of growth, collaboration, and innovation within his teams.
Outside of work, Scott is deeply committed to family, friends, and personal well-being. He prioritizes physical and mental health, nutrition, and outdoor activities, often found hiking or attending sporting events.
Scott Roth
Vice President, Technology
Chris is a retired Army Colonel with 30 years of active federal service. He twice deployed to combat, led a variety of operational and training organizations, and served as an Assistant Professor of Strategy at the National Defense University. At Mira, Chris provides strategic direction and oversight for all operational and logistical functions, integrates resources, and leads cross-functional collaboration to support corporate goals and objectives.
In 2025, Chris co-founded the 1-5 CAV Black Knight Foundation, a non-profit veteran support organization, and serves on its board of directors. Chris is a certified instructor with Simon Sinek’s Optimism Company and is an Associate Certified Coach (ACC) with the International Coaching Federation.
Chris holds a BS in Environmental Engineering from the United States Military Academy at West Point, and a Master of Arts in Strategic Studies from the U.S. Army War College. He is also a graduate of the Advanced Military Studies Program, Command & General Staff College, and Ranger School.
Chris Rogers
Vice President, Operations
David Adolfson is the Director of Revenue Cycle Management at Mira Precision Health, bringing decades of expertise in healthcare operations, financial management, and compliance. He has a diverse background, having served as Field Service Manager at Millennium Health and Director of Operations at A Ray of Hope Counseling and Health Services. David’s experience spans across laboratory services, payer markets, and revenue management, making him a key asset in optimizing financial workflows and ensuring compliance within Mira’s precision medicine initiatives.
David has extensive experience as a certified medical coder and has successfully managed healthcare teams, improving operational efficiency across various roles, including at AssureX Health and Hoxworth Blood Center. A proud U.S. Army veteran, David served as a Combat Medic during Operation Desert Storm, where he honed his leadership and organizational skills in critical, high-pressure environments.
Dave Adolfson
Director, Revenue Cycle Management
Join our growing team.
See if we have any open positions at the moment.
Values that guide us
Integrity
Innovation
Improved Patient Access
Honesty
Trust
Improved Care Delivery
Transparent
Customer Focus
